nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—CYP2D6—Lomustine—brain cancer	0.0651	0.253	CbGbCtD
Quetiapine—CYP2D6—Hydroxyurea—brain cancer	0.0494	0.192	CbGbCtD
Quetiapine—CYP3A4—Temozolomide—brain cancer	0.0487	0.19	CbGbCtD
Quetiapine—CYP3A4—Lomustine—brain cancer	0.0414	0.161	CbGbCtD
Quetiapine—CYP3A5—Etoposide—brain cancer	0.0257	0.0999	CbGbCtD
Quetiapine—ABCB1—Etoposide—brain cancer	0.0167	0.065	CbGbCtD
Quetiapine—HTR1D—meninx—brain cancer	0.0138	0.0494	CbGeAlD
Quetiapine—HTR3A—fourth ventricle—brain cancer	0.0134	0.0481	CbGeAlD
Quetiapine—HTR1B—dura mater—brain cancer	0.0131	0.0469	CbGeAlD
Quetiapine—HTR1D—dura mater—brain cancer	0.0127	0.0454	CbGeAlD
Quetiapine—HTR2C—choroid plexus—brain cancer	0.0107	0.0382	CbGeAlD
Quetiapine—CYP3A4—Etoposide—brain cancer	0.01	0.0389	CbGbCtD
Quetiapine—HTR1B—trigeminal nerve—brain cancer	0.00564	0.0202	CbGeAlD
Quetiapine—DRD3—telencephalic ventricle—brain cancer	0.00563	0.0201	CbGeAlD
Quetiapine—HTR1D—trigeminal nerve—brain cancer	0.00546	0.0195	CbGeAlD
Quetiapine—HTR2A—choroid plexus—brain cancer	0.00536	0.0192	CbGeAlD
Quetiapine—HTR3A—cranial nerve—brain cancer	0.00479	0.0171	CbGeAlD
Quetiapine—HRH1—nose—brain cancer	0.00414	0.0148	CbGeAlD
Quetiapine—Trifluoperazine—S100A4—brain cancer	0.0041	0.62	CrCbGaD
Quetiapine—DRD1—telencephalic ventricle—brain cancer	0.00403	0.0144	CbGeAlD
Quetiapine—HTR1B—cranial nerve—brain cancer	0.00402	0.0144	CbGeAlD
Quetiapine—HTR7—vein—brain cancer	0.00393	0.0141	CbGeAlD
Quetiapine—HTR1D—cranial nerve—brain cancer	0.00389	0.0139	CbGeAlD
Quetiapine—HTR6—ganglion—brain cancer	0.00337	0.0121	CbGeAlD
Quetiapine—DRD5—ganglion—brain cancer	0.00328	0.0118	CbGeAlD
Quetiapine—HTR1B—telencephalic ventricle—brain cancer	0.00327	0.0117	CbGeAlD
Quetiapine—HTR1D—telencephalic ventricle—brain cancer	0.00316	0.0113	CbGeAlD
Quetiapine—HTR2C—telencephalic ventricle—brain cancer	0.00313	0.0112	CbGeAlD
Quetiapine—HTR7—cranial nerve—brain cancer	0.0031	0.0111	CbGeAlD
Quetiapine—HTR7—pons—brain cancer	0.00306	0.011	CbGeAlD
Quetiapine—HTR2A—trigeminal nerve—brain cancer	0.00271	0.0097	CbGeAlD
Quetiapine—HTR2A—cerebellar cortex—brain cancer	0.0027	0.00966	CbGeAlD
Quetiapine—HTR1A—telencephalic ventricle—brain cancer	0.00264	0.00943	CbGeAlD
Quetiapine—HTR7—telencephalic ventricle—brain cancer	0.00252	0.00901	CbGeAlD
Quetiapine—DRD1—ganglion—brain cancer	0.00251	0.00898	CbGeAlD
Quetiapine—HTR2A—vein—brain cancer	0.00245	0.00877	CbGeAlD
Quetiapine—HTR3A—ganglion—brain cancer	0.00242	0.00867	CbGeAlD
Quetiapine—DRD2—telencephalic ventricle—brain cancer	0.00238	0.00852	CbGeAlD
Quetiapine—HTR1B—ganglion—brain cancer	0.00203	0.00727	CbGeAlD
Quetiapine—HTR1D—ganglion—brain cancer	0.00197	0.00704	CbGeAlD
Quetiapine—HTR2C—ganglion—brain cancer	0.00195	0.00697	CbGeAlD
Quetiapine—HTR2A—cranial nerve—brain cancer	0.00193	0.00691	CbGeAlD
Quetiapine—HTR2A—pons—brain cancer	0.00191	0.00683	CbGeAlD
Quetiapine—HTR1E—brainstem—brain cancer	0.00187	0.00669	CbGeAlD
Quetiapine—HTR1E—telencephalon—brain cancer	0.00166	0.00593	CbGeAlD
Quetiapine—HTR1A—ganglion—brain cancer	0.00164	0.00587	CbGeAlD
Quetiapine—HTR1B—blood vessel—brain cancer	0.00162	0.00578	CbGeAlD
Quetiapine—HTR2A—telencephalic ventricle—brain cancer	0.00157	0.00562	CbGeAlD
Quetiapine—HTR7—ganglion—brain cancer	0.00157	0.00561	CbGeAlD
Quetiapine—HTR1D—blood vessel—brain cancer	0.00157	0.0056	CbGeAlD
Quetiapine—DRD2—ganglion—brain cancer	0.00148	0.0053	CbGeAlD
Quetiapine—HTR2A—pineal body—brain cancer	0.00136	0.00488	CbGeAlD
Quetiapine—HTR7—endothelium—brain cancer	0.00135	0.00484	CbGeAlD
Quetiapine—HTR6—telencephalon—brain cancer	0.0013	0.00466	CbGeAlD
Quetiapine—DRD5—telencephalon—brain cancer	0.00127	0.00453	CbGeAlD
Quetiapine—HTR7—blood vessel—brain cancer	0.00125	0.00446	CbGeAlD
Quetiapine—HTR1A—hindbrain—brain cancer	0.00124	0.00445	CbGeAlD
Quetiapine—HTR7—hindbrain—brain cancer	0.00119	0.00425	CbGeAlD
Quetiapine—ADRA1A—hindbrain—brain cancer	0.00115	0.0041	CbGeAlD
Quetiapine—DRD2—hindbrain—brain cancer	0.00112	0.00402	CbGeAlD
Quetiapine—DRD1—brainstem—brain cancer	0.00109	0.0039	CbGeAlD
Quetiapine—HTR3A—brainstem—brain cancer	0.00105	0.00377	CbGeAlD
Quetiapine—HTR1E—head—brain cancer	0.00103	0.00369	CbGeAlD
Quetiapine—ADRA1D—telencephalon—brain cancer	0.00102	0.00363	CbGeAlD
Quetiapine—H1F0—telencephalon—brain cancer	0.00098	0.00351	CbGeAlD
Quetiapine—HTR2A—ganglion—brain cancer	0.000978	0.0035	CbGeAlD
Quetiapine—DRD1—telencephalon—brain cancer	0.000968	0.00346	CbGeAlD
Quetiapine—HTR1E—central nervous system—brain cancer	0.000943	0.00337	CbGeAlD
Quetiapine—HTR3A—telencephalon—brain cancer	0.000935	0.00335	CbGeAlD
Quetiapine—Olanzapine—CYP2C9—brain cancer	0.000933	0.141	CrCbGaD
Quetiapine—CHRM4—head—brain cancer	0.000906	0.00324	CbGeAlD
Quetiapine—HTR1B—brainstem—brain cancer	0.000884	0.00316	CbGeAlD
Quetiapine—DRD4—brain—brain cancer	0.000868	0.00311	CbGeAlD
Quetiapine—HTR1D—brainstem—brain cancer	0.000856	0.00306	CbGeAlD
Quetiapine—HTR2C—brainstem—brain cancer	0.000848	0.00303	CbGeAlD
Quetiapine—HTR2A—endothelium—brain cancer	0.000843	0.00302	CbGeAlD
Quetiapine—DRD3—head—brain cancer	0.000842	0.00301	CbGeAlD
Quetiapine—CYP3A7—endocrine gland—brain cancer	0.000834	0.00298	CbGeAlD
Quetiapine—CHRM4—central nervous system—brain cancer	0.000827	0.00296	CbGeAlD
Quetiapine—H1F0—gonad—brain cancer	0.000818	0.00293	CbGeAlD
Quetiapine—HTR6—head—brain cancer	0.00081	0.0029	CbGeAlD
Quetiapine—DRD5—endocrine gland—brain cancer	0.000799	0.00286	CbGeAlD
Quetiapine—H1F0—pituitary gland—brain cancer	0.000798	0.00286	CbGeAlD
Quetiapine—DRD5—head—brain cancer	0.000789	0.00282	CbGeAlD
Quetiapine—HTR1B—telencephalon—brain cancer	0.000784	0.00281	CbGeAlD
Quetiapine—CHRM2—telencephalon—brain cancer	0.00078	0.00279	CbGeAlD
Quetiapine—HTR2A—blood vessel—brain cancer	0.000778	0.00278	CbGeAlD
Quetiapine—H1F0—medulla oblongata—brain cancer	0.00077	0.00276	CbGeAlD
Quetiapine—DRD3—central nervous system—brain cancer	0.000769	0.00275	CbGeAlD
Quetiapine—HTR1D—telencephalon—brain cancer	0.00076	0.00272	CbGeAlD
Quetiapine—HTR2C—telencephalon—brain cancer	0.000752	0.00269	CbGeAlD
Quetiapine—HTR1E—brain—brain cancer	0.000748	0.00268	CbGeAlD
Quetiapine—HTR2A—hindbrain—brain cancer	0.000742	0.00265	CbGeAlD
Quetiapine—HTR6—central nervous system—brain cancer	0.00074	0.00265	CbGeAlD
Quetiapine—DRD5—central nervous system—brain cancer	0.00072	0.00258	CbGeAlD
Quetiapine—HTR1A—brainstem—brain cancer	0.000713	0.00255	CbGeAlD
Quetiapine—CHRM1—telencephalon—brain cancer	0.00071	0.00254	CbGeAlD
Quetiapine—CHRM5—head—brain cancer	0.000708	0.00253	CbGeAlD
Quetiapine—H1F0—midbrain—brain cancer	0.000704	0.00252	CbGeAlD
Quetiapine—DRD1—midbrain—brain cancer	0.000695	0.00249	CbGeAlD
Quetiapine—H1F0—spinal cord—brain cancer	0.000687	0.00246	CbGeAlD
Quetiapine—HTR7—brainstem—brain cancer	0.000682	0.00244	CbGeAlD
Quetiapine—CYP2D6—hindbrain—brain cancer	0.000676	0.00242	CbGeAlD
Quetiapine—ADRA1A—brainstem—brain cancer	0.000658	0.00235	CbGeAlD
Quetiapine—CHRM4—brain—brain cancer	0.000656	0.00235	CbGeAlD
Quetiapine—ADRA1B—head—brain cancer	0.000647	0.00231	CbGeAlD
Quetiapine—CHRM5—central nervous system—brain cancer	0.000646	0.00231	CbGeAlD
Quetiapine—DRD2—brainstem—brain cancer	0.000645	0.00231	CbGeAlD
Quetiapine—ADRA1D—endocrine gland—brain cancer	0.000641	0.00229	CbGeAlD
Quetiapine—CHRM3—telencephalon—brain cancer	0.000636	0.00227	CbGeAlD
Quetiapine—HTR1A—telencephalon—brain cancer	0.000633	0.00226	CbGeAlD
Quetiapine—ADRA1D—head—brain cancer	0.000633	0.00226	CbGeAlD
Quetiapine—H1F0—endocrine gland—brain cancer	0.000618	0.00221	CbGeAlD
Quetiapine—H1F0—head—brain cancer	0.000611	0.00218	CbGeAlD
Quetiapine—DRD3—brain—brain cancer	0.00061	0.00218	CbGeAlD
Quetiapine—HTR7—telencephalon—brain cancer	0.000605	0.00216	CbGeAlD
Quetiapine—DRD1—head—brain cancer	0.000603	0.00216	CbGeAlD
Quetiapine—HTR2C—medulla oblongata—brain cancer	0.000591	0.00211	CbGeAlD
Quetiapine—ADRA1B—central nervous system—brain cancer	0.00059	0.00211	CbGeAlD
Quetiapine—HTR6—brain—brain cancer	0.000587	0.0021	CbGeAlD
Quetiapine—ADRA1A—telencephalon—brain cancer	0.000584	0.00209	CbGeAlD
Quetiapine—HTR3A—head—brain cancer	0.000582	0.00208	CbGeAlD
Quetiapine—ADRA1D—central nervous system—brain cancer	0.000578	0.00207	CbGeAlD
Quetiapine—Perphenazine—CYP2C9—brain cancer	0.000577	0.0872	CrCbGaD
Quetiapine—DRD2—telencephalon—brain cancer	0.000572	0.00205	CbGeAlD
Quetiapine—DRD5—brain—brain cancer	0.000572	0.00205	CbGeAlD
Quetiapine—HTR1B—midbrain—brain cancer	0.000563	0.00202	CbGeAlD
Quetiapine—H1F0—central nervous system—brain cancer	0.000557	0.00199	CbGeAlD
Quetiapine—ADRA2C—telencephalon—brain cancer	0.000556	0.00199	CbGeAlD
Quetiapine—DRD1—central nervous system—brain cancer	0.00055	0.00197	CbGeAlD
Quetiapine—HTR1B—spinal cord—brain cancer	0.00055	0.00197	CbGeAlD
Quetiapine—HTR1D—midbrain—brain cancer	0.000545	0.00195	CbGeAlD
Quetiapine—H1F0—cerebellum—brain cancer	0.000545	0.00195	CbGeAlD
Quetiapine—HTR2C—midbrain—brain cancer	0.00054	0.00193	CbGeAlD
Quetiapine—HTR3A—central nervous system—brain cancer	0.000531	0.0019	CbGeAlD
Quetiapine—HTR2C—spinal cord—brain cancer	0.000527	0.00189	CbGeAlD
Quetiapine—Promazine—CYP2C9—brain cancer	0.00052	0.0786	CrCbGaD
Quetiapine—Stomatitis—Temozolomide—brain cancer	0.000514	0.00166	CcSEcCtD
Quetiapine—CHRM5—brain—brain cancer	0.000513	0.00184	CbGeAlD
Quetiapine—Urinary tract infection—Temozolomide—brain cancer	0.000512	0.00165	CcSEcCtD
Quetiapine—ABCB1—blood vessel—brain cancer	0.00051	0.00182	CbGeAlD
Quetiapine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000507	0.00164	CcSEcCtD
Quetiapine—HTR7—gonad—brain cancer	0.000505	0.00181	CbGeAlD
Quetiapine—Insomnia—Procarbazine—brain cancer	0.000503	0.00162	CcSEcCtD
Quetiapine—Paraesthesia—Procarbazine—brain cancer	0.000499	0.00161	CcSEcCtD
Quetiapine—Hepatobiliary disease—Temozolomide—brain cancer	0.000498	0.00161	CcSEcCtD
Quetiapine—HTR1B—endocrine gland—brain cancer	0.000495	0.00177	CbGeAlD
Quetiapine—Sinusitis—Temozolomide—brain cancer	0.000494	0.0016	CcSEcCtD
Quetiapine—Somnolence—Procarbazine—brain cancer	0.000494	0.0016	CcSEcCtD
Quetiapine—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000493	0.00159	CcSEcCtD
Quetiapine—Cramp muscle—Etoposide—brain cancer	0.000493	0.00159	CcSEcCtD
Quetiapine—CHRM2—endocrine gland—brain cancer	0.000492	0.00176	CbGeAlD
Quetiapine—Haemoglobin—Carmustine—brain cancer	0.000492	0.00159	CcSEcCtD
Quetiapine—Haemorrhage—Carmustine—brain cancer	0.00049	0.00158	CcSEcCtD
Quetiapine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000489	0.00158	CcSEcCtD
Quetiapine—HTR1B—head—brain cancer	0.000489	0.00175	CbGeAlD
Quetiapine—Anaemia—Hydroxyurea—brain cancer	0.000487	0.00157	CcSEcCtD
Quetiapine—Hypoaesthesia—Carmustine—brain cancer	0.000487	0.00157	CcSEcCtD
Quetiapine—Hallucination—Carmustine—brain cancer	0.000487	0.00157	CcSEcCtD
Quetiapine—Clozapine—CYP2C9—brain cancer	0.000487	0.0736	CrCbGaD
Quetiapine—CHRM2—head—brain cancer	0.000486	0.00174	CbGeAlD
Quetiapine—Decreased appetite—Procarbazine—brain cancer	0.000483	0.00156	CcSEcCtD
Quetiapine—Alanine aminotransferase increased—Etoposide—brain cancer	0.000483	0.00156	CcSEcCtD
Quetiapine—Oedema peripheral—Carmustine—brain cancer	0.000482	0.00156	CcSEcCtD
Quetiapine—Connective tissue disorder—Carmustine—brain cancer	0.000481	0.00155	CcSEcCtD
Quetiapine—Fatigue—Procarbazine—brain cancer	0.000479	0.00155	CcSEcCtD
Quetiapine—Haemoglobin—Temozolomide—brain cancer	0.000476	0.00154	CcSEcCtD
Quetiapine—Malaise—Hydroxyurea—brain cancer	0.000475	0.00154	CcSEcCtD
Quetiapine—Constipation—Procarbazine—brain cancer	0.000475	0.00154	CcSEcCtD
Quetiapine—Pain—Procarbazine—brain cancer	0.000475	0.00154	CcSEcCtD
Quetiapine—HTR7—medulla oblongata—brain cancer	0.000475	0.0017	CbGeAlD
Quetiapine—Hepatitis—Temozolomide—brain cancer	0.000473	0.00153	CcSEcCtD
Quetiapine—Haemorrhage—Temozolomide—brain cancer	0.000473	0.00153	CcSEcCtD
Quetiapine—Dysphagia—Etoposide—brain cancer	0.000473	0.00153	CcSEcCtD
Quetiapine—HTR1D—head—brain cancer	0.000473	0.00169	CbGeAlD
Quetiapine—Leukopenia—Hydroxyurea—brain cancer	0.000472	0.00152	CcSEcCtD
Quetiapine—Visual impairment—Carmustine—brain cancer	0.000472	0.00152	CcSEcCtD
Quetiapine—Hypoaesthesia—Temozolomide—brain cancer	0.000471	0.00152	CcSEcCtD
Quetiapine—Hallucination—Temozolomide—brain cancer	0.000471	0.00152	CcSEcCtD
Quetiapine—Pharyngitis—Temozolomide—brain cancer	0.00047	0.00152	CcSEcCtD
Quetiapine—ADRA1B—brain—brain cancer	0.000469	0.00168	CbGeAlD
Quetiapine—HTR2C—head—brain cancer	0.000468	0.00168	CbGeAlD
Quetiapine—Urinary tract disorder—Temozolomide—brain cancer	0.000467	0.00151	CcSEcCtD
Quetiapine—Oedema peripheral—Temozolomide—brain cancer	0.000466	0.0015	CcSEcCtD
Quetiapine—DRD2—pituitary gland—brain cancer	0.000466	0.00167	CbGeAlD
Quetiapine—Connective tissue disorder—Temozolomide—brain cancer	0.000465	0.0015	CcSEcCtD
Quetiapine—Urethral disorder—Temozolomide—brain cancer	0.000464	0.0015	CcSEcCtD
Quetiapine—ADRA1D—brain—brain cancer	0.000459	0.00164	CbGeAlD
Quetiapine—Feeling abnormal—Procarbazine—brain cancer	0.000458	0.00148	CcSEcCtD
Quetiapine—Eye disorder—Carmustine—brain cancer	0.000458	0.00148	CcSEcCtD
Quetiapine—Convulsion—Hydroxyurea—brain cancer	0.000457	0.00147	CcSEcCtD
Quetiapine—Visual impairment—Temozolomide—brain cancer	0.000456	0.00147	CcSEcCtD
Quetiapine—Gastrointestinal pain—Procarbazine—brain cancer	0.000455	0.00147	CcSEcCtD
Quetiapine—HTR1A—midbrain—brain cancer	0.000455	0.00163	CbGeAlD
Quetiapine—ADRA2C—pituitary gland—brain cancer	0.000453	0.00162	CbGeAlD
Quetiapine—HRH1—telencephalon—brain cancer	0.000452	0.00162	CbGeAlD
Quetiapine—CHRM1—endocrine gland—brain cancer	0.000448	0.0016	CbGeAlD
Quetiapine—Erythema multiforme—Temozolomide—brain cancer	0.000447	0.00144	CcSEcCtD
Quetiapine—HTR1B—central nervous system—brain cancer	0.000446	0.0016	CbGeAlD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000446	0.00144	CcSEcCtD
Quetiapine—ADRA2A—telencephalon—brain cancer	0.000444	0.00159	CbGeAlD
Quetiapine—HTR1A—spinal cord—brain cancer	0.000444	0.00159	CbGeAlD
Quetiapine—CHRM2—central nervous system—brain cancer	0.000444	0.00159	CbGeAlD
Quetiapine—Discomfort—Hydroxyurea—brain cancer	0.000443	0.00143	CcSEcCtD
Quetiapine—H1F0—brain—brain cancer	0.000442	0.00158	CbGeAlD
Quetiapine—Neutropenia—Etoposide—brain cancer	0.000442	0.00143	CcSEcCtD
Quetiapine—CHRM1—head—brain cancer	0.000442	0.00158	CbGeAlD
Quetiapine—Eye disorder—Temozolomide—brain cancer	0.000442	0.00143	CcSEcCtD
Quetiapine—Tinnitus—Temozolomide—brain cancer	0.000441	0.00142	CcSEcCtD
Quetiapine—Abdominal pain—Procarbazine—brain cancer	0.00044	0.00142	CcSEcCtD
Quetiapine—Body temperature increased—Procarbazine—brain cancer	0.00044	0.00142	CcSEcCtD
Quetiapine—Cardiac disorder—Temozolomide—brain cancer	0.000439	0.00142	CcSEcCtD
Quetiapine—ADRA2C—medulla oblongata—brain cancer	0.000437	0.00156	CbGeAlD
Quetiapine—DRD1—brain—brain cancer	0.000437	0.00156	CbGeAlD
Quetiapine—HTR7—midbrain—brain cancer	0.000434	0.00155	CbGeAlD
Quetiapine—HTR1D—central nervous system—brain cancer	0.000432	0.00154	CbGeAlD
Quetiapine—Angiopathy—Temozolomide—brain cancer	0.000429	0.00139	CcSEcCtD
Quetiapine—Mental disorder—Carmustine—brain cancer	0.000429	0.00138	CcSEcCtD
Quetiapine—HTR2C—central nervous system—brain cancer	0.000427	0.00153	CbGeAlD
Quetiapine—Infection—Hydroxyurea—brain cancer	0.000427	0.00138	CcSEcCtD
Quetiapine—Immune system disorder—Temozolomide—brain cancer	0.000427	0.00138	CcSEcCtD
Quetiapine—Mediastinal disorder—Temozolomide—brain cancer	0.000426	0.00138	CcSEcCtD
Quetiapine—Malnutrition—Carmustine—brain cancer	0.000426	0.00138	CcSEcCtD
Quetiapine—HTR2A—brainstem—brain cancer	0.000425	0.00152	CbGeAlD
Quetiapine—Chills—Temozolomide—brain cancer	0.000425	0.00137	CcSEcCtD
Quetiapine—Pneumonia—Etoposide—brain cancer	0.000424	0.00137	CcSEcCtD
Quetiapine—HTR7—spinal cord—brain cancer	0.000424	0.00152	CbGeAlD
Quetiapine—Nervous system disorder—Hydroxyurea—brain cancer	0.000422	0.00136	CcSEcCtD
Quetiapine—HTR3A—brain—brain cancer	0.000422	0.00151	CbGeAlD
Quetiapine—Infestation—Etoposide—brain cancer	0.000422	0.00136	CcSEcCtD
Quetiapine—Infestation NOS—Etoposide—brain cancer	0.000422	0.00136	CcSEcCtD
Quetiapine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000421	0.00136	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000418	0.00135	CcSEcCtD
Quetiapine—Skin disorder—Hydroxyurea—brain cancer	0.000418	0.00135	CcSEcCtD
Quetiapine—Mental disorder—Temozolomide—brain cancer	0.000415	0.00134	CcSEcCtD
Quetiapine—Back pain—Carmustine—brain cancer	0.000412	0.00133	CcSEcCtD
Quetiapine—Malnutrition—Temozolomide—brain cancer	0.000412	0.00133	CcSEcCtD
Quetiapine—Stomatitis—Etoposide—brain cancer	0.000411	0.00133	CcSEcCtD
Quetiapine—Jaundice—Etoposide—brain cancer	0.000411	0.00133	CcSEcCtD
Quetiapine—DRD2—midbrain—brain cancer	0.000411	0.00147	CbGeAlD
Quetiapine—Anorexia—Hydroxyurea—brain cancer	0.00041	0.00132	CcSEcCtD
Quetiapine—Hypersensitivity—Procarbazine—brain cancer	0.00041	0.00132	CcSEcCtD
Quetiapine—CHRM1—central nervous system—brain cancer	0.000404	0.00144	CbGeAlD
Quetiapine—Dysgeusia—Temozolomide—brain cancer	0.000403	0.0013	CcSEcCtD
Quetiapine—Vision blurred—Carmustine—brain cancer	0.000402	0.0013	CcSEcCtD
Quetiapine—CHRM3—endocrine gland—brain cancer	0.000401	0.00143	CbGeAlD
Quetiapine—ADRA2C—midbrain—brain cancer	0.000399	0.00143	CbGeAlD
Quetiapine—Tremor—Carmustine—brain cancer	0.000399	0.00129	CcSEcCtD
Quetiapine—HTR1A—endocrine gland—brain cancer	0.000399	0.00143	CbGeAlD
Quetiapine—Asthenia—Procarbazine—brain cancer	0.000399	0.00129	CcSEcCtD
Quetiapine—Hepatobiliary disease—Etoposide—brain cancer	0.000399	0.00129	CcSEcCtD
Quetiapine—Back pain—Temozolomide—brain cancer	0.000398	0.00129	CcSEcCtD
Quetiapine—CHRM3—head—brain cancer	0.000396	0.00142	CbGeAlD
Quetiapine—HTR1A—head—brain cancer	0.000394	0.00141	CbGeAlD
Quetiapine—Anaemia—Carmustine—brain cancer	0.000394	0.00127	CcSEcCtD
Quetiapine—Agranulocytosis—Etoposide—brain cancer	0.000394	0.00127	CcSEcCtD
Quetiapine—Pruritus—Procarbazine—brain cancer	0.000393	0.00127	CcSEcCtD
Quetiapine—Agitation—Carmustine—brain cancer	0.000392	0.00126	CcSEcCtD
Quetiapine—ADRA2C—spinal cord—brain cancer	0.00039	0.00139	CbGeAlD
Quetiapine—Vision blurred—Temozolomide—brain cancer	0.000388	0.00125	CcSEcCtD
Quetiapine—CYP2D6—brainstem—brain cancer	0.000387	0.00139	CbGeAlD
Quetiapine—Tremor—Temozolomide—brain cancer	0.000386	0.00125	CcSEcCtD
Quetiapine—Dyspnoea—Hydroxyurea—brain cancer	0.000384	0.00124	CcSEcCtD
Quetiapine—Somnolence—Hydroxyurea—brain cancer	0.000383	0.00124	CcSEcCtD
Quetiapine—Ill-defined disorder—Temozolomide—brain cancer	0.000382	0.00123	CcSEcCtD
Quetiapine—HTR7—endocrine gland—brain cancer	0.000382	0.00137	CbGeAlD
Quetiapine—Leukopenia—Carmustine—brain cancer	0.000382	0.00123	CcSEcCtD
Quetiapine—Anaemia—Temozolomide—brain cancer	0.000381	0.00123	CcSEcCtD
Quetiapine—Diarrhoea—Procarbazine—brain cancer	0.00038	0.00123	CcSEcCtD
Quetiapine—Dyspepsia—Hydroxyurea—brain cancer	0.000379	0.00122	CcSEcCtD
Quetiapine—Agitation—Temozolomide—brain cancer	0.000379	0.00122	CcSEcCtD
Quetiapine—HTR2A—telencephalon—brain cancer	0.000377	0.00135	CbGeAlD
Quetiapine—HTR7—head—brain cancer	0.000377	0.00135	CbGeAlD
Quetiapine—Hypoaesthesia—Etoposide—brain cancer	0.000377	0.00122	CcSEcCtD
Quetiapine—Angioedema—Temozolomide—brain cancer	0.000376	0.00122	CcSEcCtD
Quetiapine—Decreased appetite—Hydroxyurea—brain cancer	0.000374	0.00121	CcSEcCtD
Quetiapine—Urinary tract disorder—Etoposide—brain cancer	0.000374	0.00121	CcSEcCtD
Quetiapine—CYP2C19—endocrine gland—brain cancer	0.000373	0.00133	CbGeAlD
Quetiapine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000371	0.0012	CcSEcCtD
Quetiapine—Malaise—Temozolomide—brain cancer	0.000371	0.0012	CcSEcCtD
Quetiapine—Urethral disorder—Etoposide—brain cancer	0.000371	0.0012	CcSEcCtD
Quetiapine—Fatigue—Hydroxyurea—brain cancer	0.000371	0.0012	CcSEcCtD
Quetiapine—ADRA2A—gonad—brain cancer	0.00037	0.00132	CbGeAlD
Quetiapine—Vertigo—Temozolomide—brain cancer	0.00037	0.00119	CcSEcCtD
Quetiapine—Convulsion—Carmustine—brain cancer	0.000369	0.00119	CcSEcCtD
Quetiapine—Leukopenia—Temozolomide—brain cancer	0.000369	0.00119	CcSEcCtD
Quetiapine—ADRA1A—endocrine gland—brain cancer	0.000368	0.00132	CbGeAlD
Quetiapine—Hypertension—Carmustine—brain cancer	0.000368	0.00119	CcSEcCtD
Quetiapine—Pain—Hydroxyurea—brain cancer	0.000368	0.00119	CcSEcCtD
Quetiapine—Constipation—Hydroxyurea—brain cancer	0.000368	0.00119	CcSEcCtD
Quetiapine—Dizziness—Procarbazine—brain cancer	0.000368	0.00119	CcSEcCtD
Quetiapine—Palpitations—Temozolomide—brain cancer	0.000364	0.00118	CcSEcCtD
Quetiapine—ADRA1A—head—brain cancer	0.000363	0.0013	CbGeAlD
Quetiapine—Chest pain—Carmustine—brain cancer	0.000363	0.00117	CcSEcCtD
Quetiapine—Myalgia—Carmustine—brain cancer	0.000363	0.00117	CcSEcCtD
Quetiapine—Anxiety—Carmustine—brain cancer	0.000362	0.00117	CcSEcCtD
Quetiapine—ADRA2A—pituitary gland—brain cancer	0.000361	0.00129	CbGeAlD
Quetiapine—CHRM3—central nervous system—brain cancer	0.000361	0.00129	CbGeAlD
Quetiapine—DRD2—endocrine gland—brain cancer	0.000361	0.00129	CbGeAlD
Quetiapine—HTR1A—central nervous system—brain cancer	0.00036	0.00129	CbGeAlD
Quetiapine—Cough—Temozolomide—brain cancer	0.000359	0.00116	CcSEcCtD
Quetiapine—Erythema multiforme—Etoposide—brain cancer	0.000358	0.00116	CcSEcCtD
Quetiapine—Convulsion—Temozolomide—brain cancer	0.000357	0.00115	CcSEcCtD
Quetiapine—DRD2—head—brain cancer	0.000356	0.00127	CbGeAlD
Quetiapine—Hypertension—Temozolomide—brain cancer	0.000356	0.00115	CcSEcCtD
Quetiapine—Feeling abnormal—Hydroxyurea—brain cancer	0.000355	0.00114	CcSEcCtD
Quetiapine—HTR1B—brain—brain cancer	0.000354	0.00127	CbGeAlD
Quetiapine—Eye disorder—Etoposide—brain cancer	0.000354	0.00114	CcSEcCtD
Quetiapine—Vomiting—Procarbazine—brain cancer	0.000354	0.00114	CcSEcCtD
Quetiapine—CHRM2—brain—brain cancer	0.000352	0.00126	CbGeAlD
Quetiapine—HTR1A—cerebellum—brain cancer	0.000352	0.00126	CbGeAlD
Quetiapine—Cardiac disorder—Etoposide—brain cancer	0.000351	0.00113	CcSEcCtD
Quetiapine—Confusional state—Carmustine—brain cancer	0.000351	0.00113	CcSEcCtD
Quetiapine—Myalgia—Temozolomide—brain cancer	0.000351	0.00113	CcSEcCtD
Quetiapine—Arthralgia—Temozolomide—brain cancer	0.000351	0.00113	CcSEcCtD
Quetiapine—Rash—Procarbazine—brain cancer	0.000351	0.00113	CcSEcCtD
Quetiapine—Dermatitis—Procarbazine—brain cancer	0.00035	0.00113	CcSEcCtD
Quetiapine—Anxiety—Temozolomide—brain cancer	0.000349	0.00113	CcSEcCtD
Quetiapine—ADRA2A—medulla oblongata—brain cancer	0.000349	0.00125	CbGeAlD
Quetiapine—Headache—Procarbazine—brain cancer	0.000348	0.00112	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000348	0.00112	CcSEcCtD
Quetiapine—Discomfort—Temozolomide—brain cancer	0.000346	0.00112	CcSEcCtD
Quetiapine—ADRA2C—head—brain cancer	0.000346	0.00124	CbGeAlD
Quetiapine—Infection—Carmustine—brain cancer	0.000346	0.00112	CcSEcCtD
Quetiapine—HTR7—central nervous system—brain cancer	0.000344	0.00123	CbGeAlD
Quetiapine—CYP2D6—telencephalon—brain cancer	0.000344	0.00123	CbGeAlD
Quetiapine—Angiopathy—Etoposide—brain cancer	0.000344	0.00111	CcSEcCtD
Quetiapine—Dry mouth—Temozolomide—brain cancer	0.000343	0.00111	CcSEcCtD
Quetiapine—HTR1D—brain—brain cancer	0.000343	0.00123	CbGeAlD
Quetiapine—Immune system disorder—Etoposide—brain cancer	0.000342	0.0011	CcSEcCtD
Quetiapine—Mediastinal disorder—Etoposide—brain cancer	0.000341	0.0011	CcSEcCtD
Quetiapine—Thrombocytopenia—Carmustine—brain cancer	0.000341	0.0011	CcSEcCtD
Quetiapine—Body temperature increased—Hydroxyurea—brain cancer	0.00034	0.0011	CcSEcCtD
Quetiapine—Chills—Etoposide—brain cancer	0.00034	0.0011	CcSEcCtD
Quetiapine—Tachycardia—Carmustine—brain cancer	0.000339	0.0011	CcSEcCtD
Quetiapine—HTR2C—brain—brain cancer	0.000339	0.00121	CbGeAlD
Quetiapine—Confusional state—Temozolomide—brain cancer	0.000339	0.00109	CcSEcCtD
Quetiapine—Anaphylactic shock—Temozolomide—brain cancer	0.000336	0.00109	CcSEcCtD
Quetiapine—HTR7—cerebellum—brain cancer	0.000336	0.0012	CbGeAlD
Quetiapine—Infection—Temozolomide—brain cancer	0.000334	0.00108	CcSEcCtD
Quetiapine—ADRA1A—central nervous system—brain cancer	0.000332	0.00119	CbGeAlD
Quetiapine—Anorexia—Carmustine—brain cancer	0.000332	0.00107	CcSEcCtD
Quetiapine—Nausea—Procarbazine—brain cancer	0.00033	0.00107	CcSEcCtD
Quetiapine—Nervous system disorder—Temozolomide—brain cancer	0.00033	0.00106	CcSEcCtD
Quetiapine—Thrombocytopenia—Temozolomide—brain cancer	0.000329	0.00106	CcSEcCtD
Quetiapine—Skin disorder—Temozolomide—brain cancer	0.000327	0.00105	CcSEcCtD
Quetiapine—DRD2—central nervous system—brain cancer	0.000325	0.00116	CbGeAlD
Quetiapine—Hypotension—Carmustine—brain cancer	0.000325	0.00105	CcSEcCtD
Quetiapine—Hyperhidrosis—Temozolomide—brain cancer	0.000325	0.00105	CcSEcCtD
Quetiapine—ADRA1A—cerebellum—brain cancer	0.000324	0.00116	CbGeAlD
Quetiapine—Dysgeusia—Etoposide—brain cancer	0.000323	0.00104	CcSEcCtD
Quetiapine—CHRM1—brain—brain cancer	0.000321	0.00115	CbGeAlD
Quetiapine—Anorexia—Temozolomide—brain cancer	0.00032	0.00103	CcSEcCtD
Quetiapine—Back pain—Etoposide—brain cancer	0.000319	0.00103	CcSEcCtD
Quetiapine—ADRA2A—midbrain—brain cancer	0.000319	0.00114	CbGeAlD
Quetiapine—DRD2—cerebellum—brain cancer	0.000318	0.00114	CbGeAlD
Quetiapine—Hypersensitivity—Hydroxyurea—brain cancer	0.000317	0.00102	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000317	0.00102	CcSEcCtD
Quetiapine—Muscle spasms—Etoposide—brain cancer	0.000317	0.00102	CcSEcCtD
Quetiapine—ADRA2C—central nervous system—brain cancer	0.000316	0.00113	CbGeAlD
Quetiapine—HTR2A—gonad—brain cancer	0.000315	0.00113	CbGeAlD
Quetiapine—Insomnia—Carmustine—brain cancer	0.000315	0.00102	CcSEcCtD
Quetiapine—Paraesthesia—Carmustine—brain cancer	0.000312	0.00101	CcSEcCtD
Quetiapine—ADRA2A—spinal cord—brain cancer	0.000311	0.00111	CbGeAlD
Quetiapine—Dyspnoea—Carmustine—brain cancer	0.00031	0.001	CcSEcCtD
Quetiapine—Somnolence—Carmustine—brain cancer	0.000309	0.000998	CcSEcCtD
Quetiapine—ADRA2C—cerebellum—brain cancer	0.000309	0.00111	CbGeAlD
Quetiapine—Asthenia—Hydroxyurea—brain cancer	0.000309	0.000997	CcSEcCtD
Quetiapine—HTR2A—pituitary gland—brain cancer	0.000307	0.0011	CbGeAlD
Quetiapine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000306	0.000989	CcSEcCtD
Quetiapine—Ill-defined disorder—Etoposide—brain cancer	0.000306	0.000987	CcSEcCtD
Quetiapine—Anaemia—Etoposide—brain cancer	0.000305	0.000984	CcSEcCtD
Quetiapine—Insomnia—Temozolomide—brain cancer	0.000304	0.000982	CcSEcCtD
Quetiapine—Decreased appetite—Carmustine—brain cancer	0.000302	0.000976	CcSEcCtD
Quetiapine—Paraesthesia—Temozolomide—brain cancer	0.000302	0.000975	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Carmustine—brain cancer	0.0003	0.00097	CcSEcCtD
Quetiapine—Dyspnoea—Temozolomide—brain cancer	0.0003	0.000968	CcSEcCtD
Quetiapine—Somnolence—Temozolomide—brain cancer	0.000299	0.000965	CcSEcCtD
Quetiapine—Pain—Carmustine—brain cancer	0.000297	0.00096	CcSEcCtD
Quetiapine—Constipation—Carmustine—brain cancer	0.000297	0.00096	CcSEcCtD
Quetiapine—Malaise—Etoposide—brain cancer	0.000297	0.00096	CcSEcCtD
Quetiapine—HTR2A—medulla oblongata—brain cancer	0.000296	0.00106	CbGeAlD
Quetiapine—Vertigo—Etoposide—brain cancer	0.000296	0.000956	CcSEcCtD
Quetiapine—Dyspepsia—Temozolomide—brain cancer	0.000296	0.000955	CcSEcCtD
Quetiapine—Leukopenia—Etoposide—brain cancer	0.000295	0.000953	CcSEcCtD
Quetiapine—Diarrhoea—Hydroxyurea—brain cancer	0.000294	0.000951	CcSEcCtD
Quetiapine—CYP3A5—endocrine gland—brain cancer	0.000294	0.00105	CbGeAlD
Quetiapine—Decreased appetite—Temozolomide—brain cancer	0.000292	0.000943	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Temozolomide—brain cancer	0.00029	0.000937	CcSEcCtD
Quetiapine—Fatigue—Temozolomide—brain cancer	0.00029	0.000936	CcSEcCtD
Quetiapine—Loss of consciousness—Etoposide—brain cancer	0.00029	0.000935	CcSEcCtD
Quetiapine—Cough—Etoposide—brain cancer	0.000288	0.000929	CcSEcCtD
Quetiapine—Constipation—Temozolomide—brain cancer	0.000287	0.000928	CcSEcCtD
Quetiapine—Pain—Temozolomide—brain cancer	0.000287	0.000928	CcSEcCtD
Quetiapine—CHRM3—brain—brain cancer	0.000287	0.00103	CbGeAlD
Quetiapine—Feeling abnormal—Carmustine—brain cancer	0.000287	0.000925	CcSEcCtD
Quetiapine—HTR1A—brain—brain cancer	0.000286	0.00102	CbGeAlD
Quetiapine—Convulsion—Etoposide—brain cancer	0.000286	0.000922	CcSEcCtD
Quetiapine—HRH1—endocrine gland—brain cancer	0.000285	0.00102	CbGeAlD
Quetiapine—Hypertension—Etoposide—brain cancer	0.000285	0.000919	CcSEcCtD
Quetiapine—Dizziness—Hydroxyurea—brain cancer	0.000285	0.000919	CcSEcCtD
Quetiapine—Gastrointestinal pain—Carmustine—brain cancer	0.000284	0.000918	CcSEcCtD
Quetiapine—HRH1—head—brain cancer	0.000281	0.00101	CbGeAlD
Quetiapine—Chest pain—Etoposide—brain cancer	0.000281	0.000906	CcSEcCtD
Quetiapine—ADRA2A—endocrine gland—brain cancer	0.00028	0.001	CbGeAlD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000279	0.0009	CcSEcCtD
Quetiapine—Discomfort—Etoposide—brain cancer	0.000277	0.000895	CcSEcCtD
Quetiapine—Feeling abnormal—Temozolomide—brain cancer	0.000277	0.000894	CcSEcCtD
Quetiapine—ADRA2A—head—brain cancer	0.000276	0.000988	CbGeAlD
Quetiapine—Abdominal pain—Carmustine—brain cancer	0.000275	0.000888	CcSEcCtD
Quetiapine—Body temperature increased—Carmustine—brain cancer	0.000275	0.000888	CcSEcCtD
Quetiapine—Gastrointestinal pain—Temozolomide—brain cancer	0.000275	0.000887	CcSEcCtD
Quetiapine—Vomiting—Hydroxyurea—brain cancer	0.000274	0.000883	CcSEcCtD
Quetiapine—HTR7—brain—brain cancer	0.000273	0.000977	CbGeAlD
Quetiapine—Rash—Hydroxyurea—brain cancer	0.000271	0.000876	CcSEcCtD
Quetiapine—Confusional state—Etoposide—brain cancer	0.000271	0.000876	CcSEcCtD
Quetiapine—Dermatitis—Hydroxyurea—brain cancer	0.000271	0.000875	CcSEcCtD
Quetiapine—HTR2A—midbrain—brain cancer	0.000271	0.000969	CbGeAlD
Quetiapine—Headache—Hydroxyurea—brain cancer	0.00027	0.00087	CcSEcCtD
Quetiapine—Anaphylactic shock—Etoposide—brain cancer	0.000269	0.000868	CcSEcCtD
Quetiapine—Infection—Etoposide—brain cancer	0.000267	0.000863	CcSEcCtD
Quetiapine—Abdominal pain—Temozolomide—brain cancer	0.000266	0.000858	CcSEcCtD
Quetiapine—Body temperature increased—Temozolomide—brain cancer	0.000266	0.000858	CcSEcCtD
Quetiapine—HTR2A—spinal cord—brain cancer	0.000264	0.000946	CbGeAlD
Quetiapine—Thrombocytopenia—Etoposide—brain cancer	0.000263	0.00085	CcSEcCtD
Quetiapine—ADRA1A—brain—brain cancer	0.000263	0.000942	CbGeAlD
Quetiapine—Tachycardia—Etoposide—brain cancer	0.000263	0.000848	CcSEcCtD
Quetiapine—Skin disorder—Etoposide—brain cancer	0.000261	0.000844	CcSEcCtD
Quetiapine—Hyperhidrosis—Etoposide—brain cancer	0.00026	0.00084	CcSEcCtD
Quetiapine—DRD2—brain—brain cancer	0.000258	0.000923	CbGeAlD
Quetiapine—HRH1—central nervous system—brain cancer	0.000257	0.000918	CbGeAlD
Quetiapine—Anorexia—Etoposide—brain cancer	0.000256	0.000828	CcSEcCtD
Quetiapine—Hypersensitivity—Carmustine—brain cancer	0.000256	0.000827	CcSEcCtD
Quetiapine—Nausea—Hydroxyurea—brain cancer	0.000256	0.000825	CcSEcCtD
Quetiapine—ADRA2A—central nervous system—brain cancer	0.000252	0.000902	CbGeAlD
Quetiapine—Hypotension—Etoposide—brain cancer	0.000251	0.000812	CcSEcCtD
Quetiapine—ADRA2C—brain—brain cancer	0.000251	0.000898	CbGeAlD
Quetiapine—Asthenia—Carmustine—brain cancer	0.00025	0.000806	CcSEcCtD
Quetiapine—Hypersensitivity—Temozolomide—brain cancer	0.000248	0.0008	CcSEcCtD
Quetiapine—ABCB1—telencephalon—brain cancer	0.000247	0.000884	CbGeAlD
Quetiapine—ADRA2A—cerebellum—brain cancer	0.000247	0.000882	CbGeAlD
Quetiapine—Paraesthesia—Etoposide—brain cancer	0.000242	0.00078	CcSEcCtD
Quetiapine—Asthenia—Temozolomide—brain cancer	0.000241	0.000779	CcSEcCtD
Quetiapine—Dyspnoea—Etoposide—brain cancer	0.00024	0.000774	CcSEcCtD
Quetiapine—Somnolence—Etoposide—brain cancer	0.000239	0.000772	CcSEcCtD
Quetiapine—Diarrhoea—Carmustine—brain cancer	0.000238	0.000768	CcSEcCtD
Quetiapine—HTR2A—endocrine gland—brain cancer	0.000238	0.000851	CbGeAlD
Quetiapine—Pruritus—Temozolomide—brain cancer	0.000238	0.000768	CcSEcCtD
Quetiapine—HTR2A—head—brain cancer	0.000235	0.00084	CbGeAlD
Quetiapine—Decreased appetite—Etoposide—brain cancer	0.000234	0.000755	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Etoposide—brain cancer	0.000232	0.00075	CcSEcCtD
Quetiapine—Fatigue—Etoposide—brain cancer	0.000232	0.000749	CcSEcCtD
Quetiapine—Dizziness—Carmustine—brain cancer	0.00023	0.000743	CcSEcCtD
Quetiapine—Pain—Etoposide—brain cancer	0.00023	0.000743	CcSEcCtD
Quetiapine—Constipation—Etoposide—brain cancer	0.00023	0.000743	CcSEcCtD
Quetiapine—Diarrhoea—Temozolomide—brain cancer	0.00023	0.000743	CcSEcCtD
Quetiapine—Dizziness—Temozolomide—brain cancer	0.000222	0.000718	CcSEcCtD
Quetiapine—Feeling abnormal—Etoposide—brain cancer	0.000222	0.000716	CcSEcCtD
Quetiapine—Vomiting—Carmustine—brain cancer	0.000221	0.000714	CcSEcCtD
Quetiapine—CYP3A4—endocrine gland—brain cancer	0.00022	0.000788	CbGeAlD
Quetiapine—Gastrointestinal pain—Etoposide—brain cancer	0.00022	0.00071	CcSEcCtD
Quetiapine—Rash—Carmustine—brain cancer	0.000219	0.000708	CcSEcCtD
Quetiapine—Dermatitis—Carmustine—brain cancer	0.000219	0.000707	CcSEcCtD
Quetiapine—Headache—Carmustine—brain cancer	0.000218	0.000704	CcSEcCtD
Quetiapine—CYP2D6—endocrine gland—brain cancer	0.000217	0.000776	CbGeAlD
Quetiapine—HTR2A—central nervous system—brain cancer	0.000214	0.000767	CbGeAlD
Quetiapine—CYP2D6—head—brain cancer	0.000214	0.000766	CbGeAlD
Quetiapine—Vomiting—Temozolomide—brain cancer	0.000214	0.00069	CcSEcCtD
Quetiapine—Abdominal pain—Etoposide—brain cancer	0.000213	0.000687	CcSEcCtD
Quetiapine—Body temperature increased—Etoposide—brain cancer	0.000213	0.000687	CcSEcCtD
Quetiapine—Rash—Temozolomide—brain cancer	0.000212	0.000684	CcSEcCtD
Quetiapine—Dermatitis—Temozolomide—brain cancer	0.000212	0.000684	CcSEcCtD
Quetiapine—Headache—Temozolomide—brain cancer	0.000211	0.00068	CcSEcCtD
Quetiapine—HTR2A—cerebellum—brain cancer	0.00021	0.00075	CbGeAlD
Quetiapine—Nausea—Carmustine—brain cancer	0.000207	0.000667	CcSEcCtD
Quetiapine—ABCB1—gonad—brain cancer	0.000206	0.000738	CbGeAlD
Quetiapine—HRH1—brain—brain cancer	0.000204	0.000729	CbGeAlD
Quetiapine—ABCB1—pituitary gland—brain cancer	0.000201	0.00072	CbGeAlD
Quetiapine—ADRA2A—brain—brain cancer	0.0002	0.000716	CbGeAlD
Quetiapine—Nausea—Temozolomide—brain cancer	0.0002	0.000645	CcSEcCtD
Quetiapine—CYP3A4—central nervous system—brain cancer	0.000199	0.00071	CbGeAlD
Quetiapine—Hypersensitivity—Etoposide—brain cancer	0.000198	0.00064	CcSEcCtD
Quetiapine—CYP2D6—central nervous system—brain cancer	0.000195	0.000699	CbGeAlD
Quetiapine—ABCB1—medulla oblongata—brain cancer	0.000194	0.000695	CbGeAlD
Quetiapine—Asthenia—Etoposide—brain cancer	0.000193	0.000623	CcSEcCtD
Quetiapine—CYP2D6—cerebellum—brain cancer	0.000191	0.000683	CbGeAlD
Quetiapine—Pruritus—Etoposide—brain cancer	0.00019	0.000614	CcSEcCtD
Quetiapine—Diarrhoea—Etoposide—brain cancer	0.000184	0.000594	CcSEcCtD
Quetiapine—Dizziness—Etoposide—brain cancer	0.000178	0.000574	CcSEcCtD
Quetiapine—ABCB1—midbrain—brain cancer	0.000178	0.000635	CbGeAlD
Quetiapine—ABCB1—spinal cord—brain cancer	0.000173	0.00062	CbGeAlD
Quetiapine—Vomiting—Etoposide—brain cancer	0.000171	0.000552	CcSEcCtD
Quetiapine—HTR2A—brain—brain cancer	0.00017	0.000609	CbGeAlD
Quetiapine—Rash—Etoposide—brain cancer	0.00017	0.000548	CcSEcCtD
Quetiapine—Dermatitis—Etoposide—brain cancer	0.000169	0.000547	CcSEcCtD
Quetiapine—Headache—Etoposide—brain cancer	0.000169	0.000544	CcSEcCtD
Quetiapine—Nausea—Etoposide—brain cancer	0.00016	0.000516	CcSEcCtD
Quetiapine—ABCB1—endocrine gland—brain cancer	0.000156	0.000558	CbGeAlD
Quetiapine—CYP2D6—brain—brain cancer	0.000155	0.000555	CbGeAlD
Quetiapine—ABCB1—head—brain cancer	0.000154	0.000551	CbGeAlD
Quetiapine—ABCB1—central nervous system—brain cancer	0.000141	0.000503	CbGeAlD
Quetiapine—ABCB1—cerebellum—brain cancer	0.000137	0.000491	CbGeAlD
Quetiapine—ABCB1—brain—brain cancer	0.000112	0.000399	CbGeAlD
Quetiapine—HTR6—Signaling Pathways—CCND1—brain cancer	1.13e-05	7.7e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—CCND1—brain cancer	1.13e-05	7.69e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—IL2—brain cancer	1.13e-05	7.67e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—CCND1—brain cancer	1.12e-05	7.64e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—CTNNB1—brain cancer	1.12e-05	7.62e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—CTNNB1—brain cancer	1.12e-05	7.61e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—EGFR—brain cancer	1.11e-05	7.57e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—CTNNB1—brain cancer	1.11e-05	7.56e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—IL2—brain cancer	1.11e-05	7.55e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—RELA—brain cancer	1.11e-05	7.55e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—EGFR—brain cancer	1.11e-05	7.53e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—ERBB2—brain cancer	1.1e-05	7.5e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—CCND1—brain cancer	1.1e-05	7.48e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—IL2—brain cancer	1.1e-05	7.45e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—RELA—brain cancer	1.1e-05	7.44e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—RELA—brain cancer	1.1e-05	7.44e-05	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—TP53—brain cancer	1.09e-05	7.42e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—CTNNB1—brain cancer	1.09e-05	7.41e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—ERBB2—brain cancer	1.09e-05	7.4e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—ERBB2—brain cancer	1.09e-05	7.4e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IRS2—brain cancer	1.09e-05	7.39e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—CCND1—brain cancer	1.08e-05	7.36e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—EGFR—brain cancer	1.08e-05	7.32e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—PIK3CG—brain cancer	1.07e-05	7.29e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—APC—brain cancer	1.07e-05	7.29e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—CTNNB1—brain cancer	1.07e-05	7.29e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—CCND1—brain cancer	1.07e-05	7.26e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ENO2—brain cancer	1.07e-05	7.25e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—EGFR—brain cancer	1.06e-05	7.2e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—CTNNB1—brain cancer	1.06e-05	7.19e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—PIK3CG—brain cancer	1.06e-05	7.17e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—APC—brain cancer	1.06e-05	7.17e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—PIK3CG—brain cancer	1.05e-05	7.16e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—APC—brain cancer	1.05e-05	7.16e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PIK3CG—brain cancer	1.05e-05	7.15e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—APC—brain cancer	1.05e-05	7.14e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—PIK3CG—brain cancer	1.05e-05	7.14e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—IL2—brain cancer	1.05e-05	7.13e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—PIK3CG—brain cancer	1.05e-05	7.11e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—APC—brain cancer	1.05e-05	7.11e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—APC—brain cancer	1.04e-05	7.04e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PIK3CG—brain cancer	1.04e-05	7.04e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	1.03e-05	7.02e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—APC—brain cancer	1.03e-05	7.02e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—CCND1—brain cancer	1.02e-05	6.95e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—CTNNB1—brain cancer	1.01e-05	6.88e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—IL2—brain cancer	1e-05	6.8e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—RELA—brain cancer	9.89e-06	6.72e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—VEGFA—brain cancer	9.87e-06	6.71e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—IL2—brain cancer	9.86e-06	6.7e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—IL2—brain cancer	9.86e-06	6.7e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—VEGFA—brain cancer	9.86e-06	6.7e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—ERBB2—brain cancer	9.83e-06	6.68e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—VEGFA—brain cancer	9.79e-06	6.66e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—STAT3—brain cancer	9.77e-06	6.64e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—EGFR—brain cancer	9.77e-06	6.64e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—STAT3—brain cancer	9.76e-06	6.64e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—CCND1—brain cancer	9.75e-06	6.62e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—STAT3—brain cancer	9.7e-06	6.59e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—TP53—brain cancer	9.66e-06	6.57e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—CTNNB1—brain cancer	9.65e-06	6.56e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—CCND1—brain cancer	9.62e-06	6.54e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—CCND1—brain cancer	9.62e-06	6.54e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—EGFR—brain cancer	9.61e-06	6.54e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—APC—brain cancer	9.6e-06	6.53e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	9.6e-06	6.53e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—EGFR—brain cancer	9.59e-06	6.52e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—VEGFA—brain cancer	9.59e-06	6.52e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—EGFR—brain cancer	9.56e-06	6.5e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—RELA—brain cancer	9.55e-06	6.49e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—EGFR—brain cancer	9.53e-06	6.48e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—CTNNB1—brain cancer	9.52e-06	6.47e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	9.52e-06	6.47e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—STAT3—brain cancer	9.5e-06	6.45e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—RELA—brain cancer	9.5e-06	6.45e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—ERBB2—brain cancer	9.49e-06	6.45e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—EGFR—brain cancer	9.44e-06	6.42e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—VEGFA—brain cancer	9.44e-06	6.42e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—ERBB2—brain cancer	9.44e-06	6.41e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—EGFR—brain cancer	9.41e-06	6.4e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—STAT3—brain cancer	9.34e-06	6.35e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—VEGFA—brain cancer	9.31e-06	6.33e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—RELA—brain cancer	9.24e-06	6.28e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—STAT3—brain cancer	9.22e-06	6.27e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—ERBB2—brain cancer	9.18e-06	6.24e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—RELA—brain cancer	9.09e-06	6.18e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—MYC—brain cancer	9.08e-06	6.17e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—MYC—brain cancer	9.07e-06	6.17e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—ERBB2—brain cancer	9.03e-06	6.14e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—MYC—brain cancer	9.01e-06	6.13e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—VEGFA—brain cancer	8.92e-06	6.06e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—IL2—brain cancer	8.91e-06	6.05e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—EGFR—brain cancer	8.88e-06	6.04e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—EGFR—brain cancer	8.87e-06	6.03e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—STAT3—brain cancer	8.83e-06	6e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—MYC—brain cancer	8.82e-06	6e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—EGFR—brain cancer	8.81e-06	5.99e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—EGFR—brain cancer	8.75e-06	5.95e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—MYC—brain cancer	8.68e-06	5.9e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—CCND1—brain cancer	8.68e-06	5.9e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—EGFR—brain cancer	8.63e-06	5.87e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	8.6e-06	5.84e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—IL2—brain cancer	8.6e-06	5.84e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—MYC—brain cancer	8.57e-06	5.82e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—IL2—brain cancer	8.55e-06	5.81e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—VEGFA—brain cancer	8.5e-06	5.78e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—EGFR—brain cancer	8.49e-06	5.77e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—STAT3—brain cancer	8.41e-06	5.72e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—VEGFA—brain cancer	8.38e-06	5.7e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—VEGFA—brain cancer	8.38e-06	5.7e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—RELA—brain cancer	8.38e-06	5.7e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CCND1—brain cancer	8.38e-06	5.7e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—EGFR—brain cancer	8.38e-06	5.7e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CCND1—brain cancer	8.34e-06	5.67e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—ERBB2—brain cancer	8.33e-06	5.66e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IL2—brain cancer	8.32e-06	5.65e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—STAT3—brain cancer	8.3e-06	5.64e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—STAT3—brain cancer	8.3e-06	5.64e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CTNNB1—brain cancer	8.3e-06	5.64e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CTNNB1—brain cancer	8.26e-06	5.61e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—RELA—brain cancer	8.25e-06	5.61e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—RELA—brain cancer	8.23e-06	5.59e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—MYC—brain cancer	8.2e-06	5.58e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—RELA—brain cancer	8.2e-06	5.58e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—ERBB2—brain cancer	8.19e-06	5.57e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IL2—brain cancer	8.19e-06	5.56e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—ERBB2—brain cancer	8.18e-06	5.56e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—RELA—brain cancer	8.18e-06	5.56e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—ERBB2—brain cancer	8.15e-06	5.54e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3CG—brain cancer	8.13e-06	5.53e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—ERBB2—brain cancer	8.12e-06	5.52e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CCND1—brain cancer	8.11e-06	5.51e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—RELA—brain cancer	8.1e-06	5.5e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—RELA—brain cancer	8.07e-06	5.49e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—ERBB2—brain cancer	8.05e-06	5.47e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CTNNB1—brain cancer	8.03e-06	5.46e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—ERBB2—brain cancer	8.02e-06	5.45e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—EGFR—brain cancer	8.02e-06	5.45e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CCND1—brain cancer	7.98e-06	5.42e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CG—brain cancer	7.94e-06	5.4e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	7.9e-06	5.37e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—MYC—brain cancer	7.82e-06	5.31e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—MYC—brain cancer	7.71e-06	5.24e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—MYC—brain cancer	7.71e-06	5.24e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—EGFR—brain cancer	7.65e-06	5.2e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—VEGFA—brain cancer	7.57e-06	5.14e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL2—brain cancer	7.55e-06	5.13e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—EGFR—brain cancer	7.54e-06	5.13e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—EGFR—brain cancer	7.54e-06	5.13e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—RELA—brain cancer	7.5e-06	5.1e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—STAT3—brain cancer	7.49e-06	5.09e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CG—brain cancer	7.48e-06	5.09e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—TP53—brain cancer	7.46e-06	5.07e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—ERBB2—brain cancer	7.45e-06	5.07e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—TP53—brain cancer	7.45e-06	5.06e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL2—brain cancer	7.43e-06	5.05e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL2—brain cancer	7.41e-06	5.04e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—TP53—brain cancer	7.4e-06	5.03e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL2—brain cancer	7.39e-06	5.02e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL2—brain cancer	7.36e-06	5.01e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CCND1—brain cancer	7.36e-06	5e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—VEGFA—brain cancer	7.31e-06	4.97e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL2—brain cancer	7.29e-06	4.96e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CTNNB1—brain cancer	7.29e-06	4.95e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL2—brain cancer	7.27e-06	4.94e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—VEGFA—brain cancer	7.27e-06	4.94e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—TP53—brain cancer	7.25e-06	4.93e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CCND1—brain cancer	7.24e-06	4.92e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—STAT3—brain cancer	7.23e-06	4.92e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CCND1—brain cancer	7.22e-06	4.91e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CCND1—brain cancer	7.2e-06	4.89e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—STAT3—brain cancer	7.2e-06	4.89e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CCND1—brain cancer	7.18e-06	4.88e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CTNNB1—brain cancer	7.17e-06	4.87e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CTNNB1—brain cancer	7.15e-06	4.86e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CTNNB1—brain cancer	7.13e-06	4.85e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—TP53—brain cancer	7.13e-06	4.85e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CCND1—brain cancer	7.11e-06	4.83e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CTNNB1—brain cancer	7.11e-06	4.83e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CCND1—brain cancer	7.09e-06	4.82e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—VEGFA—brain cancer	7.07e-06	4.81e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CTNNB1—brain cancer	7.04e-06	4.78e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—TP53—brain cancer	7.03e-06	4.78e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	7.02e-06	4.77e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—STAT3—brain cancer	7e-06	4.76e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MYC—brain cancer	6.96e-06	4.73e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—VEGFA—brain cancer	6.96e-06	4.73e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—STAT3—brain cancer	6.89e-06	4.68e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—EGFR—brain cancer	6.81e-06	4.63e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL2—brain cancer	6.76e-06	4.59e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TP53—brain cancer	6.74e-06	4.58e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MYC—brain cancer	6.72e-06	4.57e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MYC—brain cancer	6.69e-06	4.55e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CCND1—brain cancer	6.59e-06	4.48e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—EGFR—brain cancer	6.57e-06	4.47e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—EGFR—brain cancer	6.54e-06	4.45e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	6.52e-06	4.43e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MYC—brain cancer	6.5e-06	4.42e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TP53—brain cancer	6.42e-06	4.36e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—VEGFA—brain cancer	6.41e-06	4.36e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MYC—brain cancer	6.4e-06	4.35e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—EGFR—brain cancer	6.36e-06	4.32e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—STAT3—brain cancer	6.35e-06	4.32e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TP53—brain cancer	6.33e-06	4.31e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TP53—brain cancer	6.33e-06	4.31e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—VEGFA—brain cancer	6.31e-06	4.29e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—VEGFA—brain cancer	6.3e-06	4.28e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—VEGFA—brain cancer	6.28e-06	4.27e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—EGFR—brain cancer	6.26e-06	4.26e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—VEGFA—brain cancer	6.26e-06	4.25e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—STAT3—brain cancer	6.25e-06	4.25e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—STAT3—brain cancer	6.24e-06	4.24e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—STAT3—brain cancer	6.22e-06	4.23e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—VEGFA—brain cancer	6.2e-06	4.21e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—STAT3—brain cancer	6.2e-06	4.21e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—VEGFA—brain cancer	6.18e-06	4.2e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—STAT3—brain cancer	6.14e-06	4.17e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—STAT3—brain cancer	6.12e-06	4.16e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MYC—brain cancer	5.9e-06	4.01e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MYC—brain cancer	5.81e-06	3.95e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MYC—brain cancer	5.79e-06	3.94e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MYC—brain cancer	5.78e-06	3.93e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EGFR—brain cancer	5.77e-06	3.92e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MYC—brain cancer	5.76e-06	3.91e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—VEGFA—brain cancer	5.74e-06	3.9e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TP53—brain cancer	5.72e-06	3.89e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MYC—brain cancer	5.7e-06	3.88e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MYC—brain cancer	5.69e-06	3.87e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—STAT3—brain cancer	5.69e-06	3.86e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EGFR—brain cancer	5.68e-06	3.86e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EGFR—brain cancer	5.67e-06	3.85e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EGFR—brain cancer	5.65e-06	3.84e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EGFR—brain cancer	5.63e-06	3.83e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EGFR—brain cancer	5.58e-06	3.79e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EGFR—brain cancer	5.56e-06	3.78e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TP53—brain cancer	5.52e-06	3.75e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TP53—brain cancer	5.49e-06	3.73e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TP53—brain cancer	5.34e-06	3.63e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MYC—brain cancer	5.28e-06	3.59e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TP53—brain cancer	5.26e-06	3.57e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EGFR—brain cancer	5.17e-06	3.51e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CG—brain cancer	4.89e-06	3.33e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TP53—brain cancer	4.85e-06	3.29e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TP53—brain cancer	4.77e-06	3.24e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TP53—brain cancer	4.76e-06	3.23e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TP53—brain cancer	4.74e-06	3.22e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TP53—brain cancer	4.73e-06	3.21e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TP53—brain cancer	4.68e-06	3.18e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TP53—brain cancer	4.67e-06	3.17e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TP53—brain cancer	4.34e-06	2.95e-05	CbGpPWpGaD
